DHA treatment of children suffering from NAFLD increased the FFAR4 expression in hepatocytes and reduced nuclear NFκB translocation in hepatocytes and liver macrophages, as well as reduced hepatic progenitor cell activation and the number of inflamed macrophages in the liver (36). The gene discussed is FFAR4; the disease is metabolic dysfunction-associated steatotic liver disease.